High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients

Anesthesia and Analgesia

Volumn 110, Issue 2, 2010, Pages 350-353

  Murkin, John M ^a   Falter, Florian ^b   Granton, Jeff ^a   Young, Bryan ^a   Burt, Christiana ^b   Chu, Michael ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; AORTA RECONSTRUCTION; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN ISCHEMIA; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; FEMALE; GRAND MAL SEIZURE; HEART SURGERY; HEART TRANSPLANTATION; HEMOSTASIS; HUMAN; LOADING DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE REPAIR; MYOCLONUS SEIZURE; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; SURGICAL PATIENT; SURGICAL THROMBECTOMY; TRICUSPID VALVE REPLACEMENT; BLEEDING; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; SEIZURE;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HUMANS; INTRAOPERATIVE CARE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEIZURES; TRANEXAMIC ACID;

EID: 76249100902     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181c92b23     Document Type: Article

References (31)

1. Unsworth-White MJ, Herriot A, Valencia O, Poloniecki J, Smith EE, Murday AJ, Parker DJ, Treasure T. Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality. Ann Thorac Surg 1995;59:664-667
2. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-2552
3. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA II, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83:S27-86
4. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-31
5. Available at: http://www.fda.gov/CDER/DRUG/infopage/ aprotinin/default. htm
6. Available at: http://www.pharmacists.ca/content/hcp/tools/ drugnews/discontinued.htm
7. Available at: http://www.medsafe.govt.nz/Profs/adverse/ Minutes125.htm#3.1
8. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 1997;85:1258-1267
9. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006;34:1608-1616
10. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA, Ghannam M, Yeo E, Djaiani G, Karski J. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-1462
11. Karski JM, Dowd NP, Joiner R, Carroll J, Peniston C, Bailey K, Glynn MF, Teasdale SJ, Cheng DC. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C). J Cardiothorac Vasc Anesth 1998;12:642-646
12. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996;335:1857-1863
13. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-365
14. Martin K, Wiesner G, Breuer T, Lange R, Tassani P. The risks of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients. Anesth Analg 2008;107: 1783-1790
15. Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 2009;35:167-171
16. Available at: http://www.cas.ca/annual-meeting/abstracts- and-refresher/poster-discussions/1-16/613047.pdf
17. Yeh HM, Lau HP, Lin PL, Sun WZ, Mok MS. Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid. Anesthesiology 2003;98:270-272
18. Wong JO, Yang SF, Tsai MH. [Accidental injection of tranexamic acid (Transamin) during spinal anesthesia]. Ma Zui Xue Za Zhi 1988;26:249-252
19. de Leede-van der Maarl MG, Hilkens P, Bosch F. The epileptogenic effect of tranexamic acid. J Neurol 1999;246:843
20. Garcha PS, Mohan CV, Sharma RM. Death after an inadvertent intrathecal injection of tranexamic acid. Anesth Analg 2007;104:241-242
21. Tsementzis SA, Meyer CH, Hitchcock ER. Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid. Neurochirurgia (Stuttg) 1992;35:74-78
22. Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien) 1990;102:1-10
23. Iplikcioglu AC, Berkman MZ. The effect of short-term antifibrinolytic therapy on experimental vasospasm. Surg Neurol 2003;59:10-6; discussion 16-17
24. Furtmuller R, Schlag MG, Berger M, Hopf R, Huck S, Sieghart W, Redl H. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002; 301:168-173
25. Schlag MG, Hopf R, Redl H. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model. Neurosurgery 2000;47:1463-1467
26. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002;97:390-399
27. Yamaura A, Nakamura T, Makino H, Hagihara Y. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm: animal experiment and a review of literature. Eur Neurol 1980;19:77-84
28. Fodstad H, Pilbrant A, Schannong M, Strömberg S. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1981; 58:1-13 (Pubitemid 11030618)
29. Schlag MG, Hopf R, Zifko U, Redl H. Epileptic seizures following cortical application of fibrin sealants containing tranexamic acid in rats. Acta Neurochir (Wien) 2002;144:63-69
30. Cavaglia M, Seshadri SG, Marchand JE, Ochocki CL, Mee RB, Bokesch PM. Increased transcription factor expression and permeability of the blood brain barrier associated with cardiopulmonary bypass in lambs. Ann Thorac Surg 2004;78:1418-1425
31. Shinar E, Rabinovici R, Heyman A, Kluger Y. Convulsions induced by aminocaproic acid infusion. DICP 1989;23:780-781